Recent Articles from Business Wire

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with Daiichi Sankyo (TSE: 4568). The collaboration will integrate AI-driven translational intelligence into the core of an antibody drug conjugate (ADC) development program of Daiichi Sankyo to move beyond standard exploratory biomarker analysis and deliver decision-ready insights that directly inform patient selection strategies, development prioritization and translational positioning.

NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced that UnionPay cardholders can now withdraw cash at thousands of Cashzone ATMs across the UK, timed to coincide with Chinese New Year celebrations.

DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, announced today that Lee Bienstock, Chief Executive Officer, will participate in 1x1 meetings at the TD Cowen 46th Annual Health Care Conference on Monday, March 2nd, and will deliver a presentation at 9:10 AM ET on that day. A webcast of the event will be available on the investor relations section of DocGo’s website at https://ir.docgo.com/.

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that the Company will release its fourth quarter and full year 2025 financial results before the open of the U.S. financial markets on Monday, March 2, 2026. Management will host a conference call and webcast at 8:30 a.m. Eastern Time that day to discuss the Company’s financial and operational results.

Energy Transfer LP (NYSE:ET) (“Energy Transfer” or the “Partnership”) today reported financial results for the quarter and year ended December 31, 2025.

APi Group Corporation (NYSE: APG) (“APi” or the “Company”) today provided an update on year-end 2025 results and net revenue and adjusted EBITDA guidance for 2026.

The DJS Law Group reminds investors of a class action lawsuit against REGENXBIO Inc. (“Regenxbio” or “the Company”) (NASDAQ: RGNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Soluna Holdings, Inc. (“Soluna” or the “Company”) (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, today announced the expansion of its partnership with Blockware, adding an additional six megawatts of capacity at Soluna’s Dorothy 1 site in west Texas.

The Association for Advancing Automation (A3) announced the launch of Age of Automation, a global advertisement feature series presented by A3 and produced by BBC StoryWorks that explores how automation is transforming industries and improving lives around the world. The series features original films and articles highlighting organizations using automation to address real-world challenges.

Sanborn, a leading provider of geospatial data and solutions, announced today that its Chief Scientist, Dr. Srini Dharmapuri, CP, CMS, PMP, has been named a Fellow of the American Society for Photogrammetry and Remote Sensing (ASPRS), the Society’s highest-level honor. The ASPRS Fellow distinction recognizes individuals who have demonstrated exceptional leadership, sustained technical contributions, and long-term service to the geospatial sciences.

BX Partners announced the launch of 12 open-architecture portfolio models on the Nitrogen Partner Store. The BX models provide financial advisors with access to nonproprietary stock-and-ETF portfolios designed to align with client risk profiles and deliver risk-adjusted performance.

NeoGenomics, Inc. (Nasdaq: NEO) (the “Company”), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its fourth-quarter and full-year results for the period ended December 31, 2025.

Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) (NYSE American: AIRI) jointly announced today that they have entered into an Agreement and Plan of Merger (“Merger Agreement”) to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. The merging of the companies will create a larger and more diversified company well-positioned to serve the needs of their government and commercial customers. After the merger, the combined company expects to remain listed on the NYSE American under the symbol AIRI.

Sunoco LP (NYSE: SUN) (“SUN” or the “Partnership”) and SunocoCorp LLC (NYSE: SUNC) (“SUNC”) today reported financial and operating results for the quarter and year ended December 31, 2025.

CoStar Group (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology, today announced the launch of Homes AI, a transformative experience powered by Microsoft Azure OpenAI, fully integrated into Homes.com, and accessible to all consumers.

Amerit Fleet Solutions (“Amerit”), the industry’s leading provider of fleet maintenance and fleet solutions, announced the expansion of its strategic acquisition program and the appointment of Adam Lev as Vice President of Corporate Development. This effort, designed to complement Amerit’s history of strong organic growth, builds on the Company’s market-leading position in the fleet solutions industry nationwide.

The Middleby Corporation (NASDAQ: MIDD) will release 2025 fourth quarter earnings on Thursday, February 26 at 7 a.m. Eastern Time. The company has scheduled a conference call to discuss the results at 10 a.m. Eastern Time on February 26. The call is accessible through the Investor Relations section of the company website at www.middleby.com. If website access is not available, attendees can join the conference via the domestic dial-in 1-844-676-5090. International participants can access the conference by dialing 1-412-634-6754.

monday.com, the AI work platform that turns strategy into execution at scale, today announced key expansions to its partner program at its sixth annual Partner Summit. The updates are designed to unlock the AI opportunity across the partner ecosystem and enable joint customers to achieve unprecedented efficiency, impact, and growth.

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026 at 3:40 PM ET.

Air Industries Group (NYSE American: AIRI), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today announced preliminary unaudited results for the year ended December 31, 2025.

Pacific Defense today announced successful delivery of the first seven Mounted Common Infrastructure (MCI) systems under the U.S. Army’s CMOSS Mounted Form Factor (CMFF) MCI program. Awarded in September 2025, the contract’s initial tranche of systems was delivered within three months of program start, demonstrating rapid execution in direct support of the Army’s accelerated modernization objectives.

Classiq, the leading quantum computing software company, Comcast and AMD today announced the completion of a groundbreaking trial aimed at improving Internet delivery by leveraging quantum algorithms to supercharge network routing resilience.

Cyera, the AI Security Platform, today announced the appointment of Brandon Sweeney as President, marking a significant milestone as the company enters its next phase following 3.4x growth over the past year. Alongside Sweeney’s appointment, Cyera added Shira Azran as Chief Legal Officer and elevated Joseph Iantosca to Chief Financial Officer and Sharon Shaked to Chief People Officer, deepening its leadership bench to meet accelerating customer demand for AI security.

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) under the accelerated approval pathway for tirabrutinib, a highly selective irreversible, second generation Bruton tyrosine kinase inhibitor, for the treatment of relapsed or refractory primary central nervous system lymphoma (R/R PCNSL). The FDA has set an action date of December 18, 2026, under the Prescription Drug User Fee Act (PDUFA).

MarketStreet today released its second national research report on small businesses, From Survival to Scale: Building Stronger, More Resilient Restaurant Businesses, revealing a widening “capability gap” between independent restaurants that remain stuck in day-to-day survival and those positioned to scale.

Today, Artisight announced its integration with Epic MyChart Bedside TV to transform the in-room television into an Epic-aware hub for inpatient care and patient engagement. The official Artisight listing is in Toolbox on Epic Showroom under the Bedside TV Hardware Category. Built with NVIDIA AI infrastructure, Artisight brings a AI-native smart hospital solution to unify bedside hardware, ambient sensing, and virtual care applications into Epic-connected inpatient workflows through a single platform.

908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time.

Ascend Elements, the global leader in circular battery materials, today announced that TDK Ventures Inc. has been named its 2025 Partner of the Year. The recognition highlights the company’s broad and sustained contributions to Ascend Elements’ strategic, commercial, and operational progress during a pivotal year for the company. The award reflects not only past contributions, but also alignment on a shared vision for the future of local critical mineral refining and energy materials.

Impart Security, a unified runtime protection platform, today announced Programmable Bot Protection, a runtime approach to bot defense that brings detection and enforcement together inside the application. Impart makes enforcement operational by letting teams see exactly what would be blocked before turning it on.

Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced it will significantly expand the Advanced Portfolio into life, health, and social sciences disciplines, with plans to launch eight new journals by the end of 2026 and more to follow over the next several years.

Rising Phoenix Capital, an alternative investment firm operating under Rising Phoenix Resources, today announced the successful full-cycle exits of multiple oil and gas mineral investment funds during 2025, marking a significant milestone for the firm’s income-focused mineral platform.

NationsBenefits, the leading healthcare fintech and supplemental benefits platform, announced a new partnership with Kinney Drugs, a trusted, employee-owned pharmacy and retail chain serving communities across New York and Vermont.

BETA Technologies, Inc. (NYSE: BETA) (“BETA” or “the Company”), an electric aerospace company, today announced that Kyle Clark, Founder and Chief Executive Officer, and Herman Cueto, Chief Financial Officer, will participate in a fireside chat at Citi’s Global Industrial Tech and Mobility Conference in Miami, FL on Wednesday, February 18, 2026 at approximately 11:20am EST.

Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases, today announced that management will present at and participate in the following investor conferences:

Starboard Value LP (together with its affiliates, “Starboard”), a significant stockholder of Tripadvisor, Inc. (“Tripadvisor” or the “Company”) (NASDAQ: TRIP), today announced that it has delivered a letter to Greg Maffei, Tripadvisor’s Chairman of the Board of Directors, Matt Goldberg, the Company’s Chief Executive Officer, and the Board of Directors, with a copy to Mike Noonan, the Company’s Chief Financial Officer.

Levin Capital Strategies (“Levin Capital” or the “Firm”), a top 10 shareholder of MarineMax, Inc. (NYSE: HZO) (“MarineMax” or the “Company”), today announced it is calling on the Company’s Board of Directors (the “Board”) to initiate an immediate review of strategic alternatives following its prior failures to capitalize on credible acquisition offers. Levin Capital believes the Board is obligated to rigorously explore all available paths to maximizing shareholder value, including by engaging with The Donerail Group (“Donerail”) following its recent submission of an all-cash offer.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has entered into a licensing agreement with Invenra Inc. (“Invenra”), a company that has developed platform technologies to discover therapeutic antibody candidates. Under the terms of the agreement, Twist will become the co-exclusive provider, together with Invenra, of Invenra’s B-Body® bispecific antibody platform (“B-Body platform”), extending Twist’s antibody discovery services.

Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today reported financial results for the fourth quarter and fiscal year ended December 27, 2025.

SunCoke Energy, Inc. (NYSE: SXC) (the "Company" or "SunCoke") today reported fourth quarter and full-year 2025 results, and provided guidance for 2026.

As fans around the world prepare to travel for one of the biggest international soccer tournaments, FlightHub has launched a new website experience designed to make planning easier and more affordable. The new landing page, Fly to the Beautiful Game, allows travelers to select a national team or host city and instantly discover flight deals aligned with match locations. The experience connects fans to travel options for soccer tournament host cities across the United States, Canada, and Mexico, including Los Angeles, Miami, and Dallas in the U.S.; Toronto and Vancouver in Canada; and Mexico City, Guadalajara, and Monterrey in Mexico.

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced that the first participant has been dosed in a Phase 1 clinical study of JANX011, a CD19-targeted bispecific engineered using the company’s proprietary Adaptive Immune Response Modulator (ARM) platform. JANX011 is being developed for autoimmune diseases and is designed to enable deep and durable immune reset through targeted depletion of CD19-expressing B cells in blood and tissue.

Manchester United plc (NYSE: MANU), announces that it will report results for the second quarter fiscal 2026 period ended 31 December 2025 via press release on 25 February 2026 at 7:00 AM EST.

PSQ Holdings, Inc. (NYSE: PSQH) (the “Company”), a payments and financial infrastructure company, today announced certain preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025. The Company expects to release full, audited financial results and file its Annual Report on Form 10-K for the year ended December 31, 2025 in mid-March 2026.

Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI systems, today announced it has been recognized as a winner in 15 categories of the Dresner Advisory Services 2025 Technology Innovation Awards and 2025 Application Innovation Awards.

Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for iberdomide combined with standard treatment (daratumumab + dexamethasone - IberDd) in patients with relapsed or refractory multiple myeloma (RRMM). Iberdomide is part of an investigational, new class of medicines called cereblon E3 ligase modulator (CELMoD) agents. The FDA has granted a Prescription Drug User Fee Act (PDUFA) date of August 17, 2026 for this indication.

USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for fourth-quarter 2025.

Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading global provider of building product solutions and cutting-edge access control technologies for the self-storage and other commercial and industrial sectors, announced today that the Company will release its fourth quarter and full year 2025 financial results after the market closes on Wednesday, March 4, 2026. A webcast and conference call will be held the following day, on Thursday, March 5, 2026, at 10:00 a.m. ET to review the Company’s fourth quarter and full year results and conduct a question-and-answer session.

Rasan Information Technology Company (Tadawul: 8313), the leading Insurtech and Fintech platform in Saudi Arabia, today announced record financial results for the full year ended 31 December 2025.

Fluor Corporation (NYSE: FLR) today announced it has completed another significant milestone involving the sale of 71 million shares of NuScale Power Corporation (NYSE: SMR), generating gross sales proceeds of $1.35 billion. Fluor has begun efforts to monetize its remaining 40 million shares, which it expects to complete in the second quarter of 2026. Including the sales in 2025, the company has captured nearly $2 billion in total proceeds to date.

Fluor Corporation (NYSE: FLR) announced financial results for its year ended December 31, 2025.

DNOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the fourth quarter and full-year 2025 on Friday, February 20, 2026 at 8:00 am (US Central Time). Financial results for the fourth quarter and the year ending December 31, 2025 are expected to be released that morning before the market opens.

Pfizer Inc. (NYSE: PFE) today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and FOLFIRI (fluorouracil, leucovorin, and irinotecan) in patients with previously untreated metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. The BRAFTOVI regimen demonstrated a statistically significant and clinically meaningful improvement in PFS, a key secondary endpoint, as assessed by blinded independent central review (BICR) compared to treatment with FOLFIRI with or without bevacizumab. Overall survival (OS), a descriptive secondary endpoint, also showed clinically meaningful prolonged improvement with the BRAFTOVI regimen.

Two Pennsylvania businesses are finding new opportunities to expand into overseas markets with help from Coupang, a U.S.-technology and Fortune 150 company that helps American companies export their goods to South Korea, Taiwan and other international markets.

TPG Mortgage Investment Trust, Inc. ("MITT," "we," the "Company," or "our") (NYSE: MITT) today reported financial results for the full year and quarter ended December 31, 2025.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing Phase 3 COMP006 trial, the second of two Phase 3 trials, which is evaluating two fixed doses of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). The primary endpoint was the difference in change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) scores between the 25 mg and 1 mg groups at Week 6. Two fixed doses – administered 3 weeks apart – of COMP360 25 mg versus 1 mg demonstrated a highly statistically significant reduction in symptom severity with a p-value of <0.001 and a clinically meaningful difference of -3.8 points in change at the primary endpoint.

Orion S.A. (NYSE: OEC), a specialty chemical company, today reported full year 2025 Net sales of $1.8 billion in 2025, a 4% decrease from the prior year, consisting of a 7% decline in price, including the pass-through effect of lower oil prices, offset by a 2% increase in volume and favorable foreign currency translation. Historically high levels of lower-tier tire imports into the Western Hemisphere and persistently soft demand in key industrial end-markets including transportation and polymers pressured our results, particularly in the second half of 2025. In response, Orion has focused on mitigating actions, including cost rationalization, inventory reduction and other optimization efforts. The company generated a consolidated Net loss of $70 million, including the non-cash goodwill impairment charge of $81 million recognized in the third quarter, and Adjusted EBITDA of $248 million. We delivered operating cash flow of $216 million and free cash flow of $55 million for 2025.

Kennedy-Wilson Holdings, Inc. (“Kennedy Wilson” or the “Company”) and Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”), today jointly announced that the Company has entered into a definitive agreement (the “Merger Agreement”) providing for Kennedy Wilson to be acquired, in an all cash-transaction, by an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of the Company, and certain other senior executives of the Company (collectively, the “KW Management Group”), together with Fairfax (collectively, the “Consortium”).

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the market opens.

Henry Schein One today announced a direct data integration between Align Technology’s iTero™ intraoral scanners and its core practice management platforms—Dentrix, Dentrix Ascend, and Dentally—creating a seamless connection between digital scanning, diagnosis, and daily operations for practices worldwide.

Lydian Energy (“Lydian”), an independent power producer specializing in the development, construction, and operation of utility-scale power infrastructure projects, today announced $689 million in financing for solar projects, AC Ranch 1 and Yellow Viking, and battery storage project, Faraday BESS. The full-stack financing is backed by CIBC and MUFG and includes a Construction-to-Term Loan, Tax Credit Bridge Loan, Co-Investment Bridge Loan, and a Letter of Credit Facility. The three projects further advance Lydian’s strategy to deliver reliable and affordable energy.

General Mills, Inc. (NYSE: GIS) will share an update on the company’s Accelerate strategy and key initiatives at today’s Consumer Analyst Group of New York (CAGNY) Conference. Chairman and Chief Executive Officer Jeff Harmening, Chief Financial Officer Kofi Bruce, and Group President of North America Retail and North America Pet Dana McNabb will outline plans to drive sustainable growth by delivering greater remarkability through the company’s global brands.

Herc Holdings Inc. (NYSE: HRI) ("Herc Holdings" or the "Company") today reported financial results for the quarter and full year ended December 31, 2025.

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter 2025 financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 26, 2026.

ImmunityBio, Inc. (NYSE: IBRX), a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the Company held productive regulatory discussions with the Saudi Food and Drug Authority (SFDA) in Riyadh, convened under the Saudi-USA Biotech Alliance hosted by the Ministry of Investment of Saudi Arabia (MISA). The engagement advanced two regulatory priorities: (1) SFDA encouraged the Company to submit a regulatory package for its recombinant BCG (rBCG) to expand BCG access in Saudi Arabia and address the ongoing global BCG shortage, and (2) ImmunityBio and SFDA initiated discussions regarding the expansion of ANKTIVA® (nogapendekin alfa inbakicept) in combination with checkpoint inhibitors (CPIs) to additional tumor types in the CPI relapsed population.

PurpleRidge (powered by RidgeBot® from Ridge Security) today announced the launch of its Automated AWS Account Audit, a direct response to recent security research showing attackers can compromise a cloud environment in as little as eight minutes.

Walker & Dunlop, Inc. announced today that it has arranged a €118,750,000 loan to refinance Zuiderpoort, an office complex in Ghent, Belgium.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ostin Technology Group Co., Ltd. (NASDAQ: OST) ordinary shares between May 11, 2025 and June 26, 2025. Ostin purports to be a manufacturer of thin-film transistor liquid crystal display modules and polarizers used in consumer electronics, commercial LCD displays, and automotive displays.

Milliman, Inc., a premier global consulting and actuarial firm, today released the 2025 year-end results of its Multiemployer Pension Funding Study (MPFS), which analyzes the funded status of all U.S. multiemployer defined benefit pension plans based on assumptions and data in their latest Form 5500 filings.

FXR Pro Fish is proud to announce a statement victory from rookie team angler Fisher Anaya, who captured first place at the 2026 Lippert Bassmaster Elite at Lake Martin with a winning total of 38 lb–10 oz. The early-season win positions Anaya as a rising contender and builds momentum as the sport’s biggest stage approaches.

Louisiana-Pacific Corporation (LP) (NYSE: LPX), a leading manufacturer of high-performance building products, today reported its financial results for the fourth quarter and year ended December 31, 2025.

Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, today reported financial results for its fourth quarter (ended Dec. 31, 2025).

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at four upcoming investor conferences:

Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today that the U.S. Department of Commerce (“DOC”) issued its final determination in the anti-dumping and countervailing duty investigations of graphite-based anode materials imported from the People’s Republic of China.

Knife River Corporation (NYSE: KNF), an aggregates-based, vertically integrated construction materials and contracting services company, today announced financial results for the fourth quarter and full-year ended December 31, 2025.

Dragos Inc., the global leader in cybersecurity for operational technology (OT) environments, today released the Dragos 2026 OT/ICS Cybersecurity Report and Year in Review report. In its 9th year, the report is the most comprehensive analysis of cyber threats facing industrial and critical infrastructure. The report identified three new threat groups targeting critical infrastructure globally and found adversaries progressing from reconnaissance to operational disruption. The findings demonstrate a maturation in adversary operations, with threat groups working as coordinated ecosystems and advancing from isolated device targeting to mapping entire industrial control systems.